BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/13/2026

1. IONS
2. FFAI
3. BIIB
4. DIS
5. AAPL
6. EVAX
7. PRTC
8. VRXA
9. KKR
10. KARD

Go back to BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9
(NASDAQ: BBIO) Delayed: 85.89 --0 (-0%)
Previous Close $85.89    52 Week High $ 
Open $85.89    52 Week Low $ 
Day High $85.89    P/E N/A 
Day Low $85.89    EPS $ 
Volume 2,574